Selected research
Industry Research
Custom Synthetic Genes Industry Research Report 2026
Market perspective
The global Custom Synthetic Genes market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Custom Synthetic Genes market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Custom Synthetic Genes market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Custom Synthetic Genes market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Custom Synthetic Genes include Azenta Life Sciences, BBI, Bio Basic, DNA 2.0 (ATUM), Eurofins Genomics, Genescript, IDT, OriGene and SBS Genetech, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Custom Synthetic Genes market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Custom Synthetic Genes.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Custom Synthetic Genes Market by Company
Azenta Life Sciences
BBI
Bio Basic
DNA 2.0 (ATUM)
Eurofins Genomics
Genescript
IDT
OriGene
SBS Genetech
Thermo Scientific
Twist Bioscience
Custom Synthetic Genes Segment by Type
Above 5000 bp
3001- 5000 bp
1001 - 3000 bp
Below 1000 bp
Custom Synthetic Genes Segment by Application
Commercial
Academic Research
Custom Synthetic Genes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Synthetic Genes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Synthetic Genes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Synthetic Genes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Custom Synthetic Genes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 5000 bp
- 3001- 5000 bp
- 1001 - 3000 bp
- Below 1000 bp
Applications
- Commercial
- Academic Research
Companies covered
- Azenta Life Sciences
- BBI
- Bio Basic
- DNA 2.0 (ATUM)
- Eurofins Genomics
- Genescript
- IDT
- OriGene
- SBS Genetech
- Thermo Scientific
- Twist Bioscience
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Custom Synthetic Genes by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Above 5000 bp
- 2.2.3 3001- 5000 bp
- 2.2.4 1001 - 3000 bp
- 2.2.5 Below 1000 bp
- 2.3 Custom Synthetic Genes by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Commercial
- 2.3.3 Academic Research
- 2.4 Assumptions and Limitations
3 Custom Synthetic Genes Breakdown Data by Type
- 3.1 Global Custom Synthetic Genes Historic Market Size by Type (2021-2026)
- 3.2 Global Custom Synthetic Genes Forecasted Market Size by Type (2027-2032)
4 Custom Synthetic Genes Breakdown Data by Application
- 4.1 Global Custom Synthetic Genes Historic Market Size by Application (2021-2026)
- 4.2 Global Custom Synthetic Genes Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Custom Synthetic Genes Market Perspective (2021-2032)
- 5.2 Global Custom Synthetic Genes Growth Trends by Region
- 5.2.1 Global Custom Synthetic Genes Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Custom Synthetic Genes Historic Market Size by Region (2021-2026)
- 5.2.3 Custom Synthetic Genes Forecasted Market Size by Region (2027-2032)
- 5.3 Custom Synthetic Genes Market Dynamics
- 5.3.1 Custom Synthetic Genes Industry Trends
- 5.3.2 Custom Synthetic Genes Market Drivers
- 5.3.3 Custom Synthetic Genes Market Challenges
- 5.3.4 Custom Synthetic Genes Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Custom Synthetic Genes Players by Revenue
- 6.1.1 Global Top Custom Synthetic Genes Players by Revenue (2021-2026)
- 6.1.2 Global Custom Synthetic Genes Revenue Market Share by Players (2021-2026)
- 6.2 Global Custom Synthetic Genes Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Custom Synthetic Genes Head Office and Area Served
- 6.4 Global Custom Synthetic Genes Players, Product Type & Application
- 6.5 Global Custom Synthetic Genes Manufacturers Established Date
- 6.6 Global Custom Synthetic Genes Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Custom Synthetic Genes Market Size (2021-2032)
- 7.2 North America Custom Synthetic Genes Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Custom Synthetic Genes Market Size by Country (2021-2026)
- 7.4 North America Custom Synthetic Genes Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Custom Synthetic Genes Market Size (2021-2032)
- 8.2 Europe Custom Synthetic Genes Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Custom Synthetic Genes Market Size by Country (2021-2026)
- 8.4 Europe Custom Synthetic Genes Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Custom Synthetic Genes Market Size (2021-2032)
- 9.2 Asia-Pacific Custom Synthetic Genes Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Custom Synthetic Genes Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Custom Synthetic Genes Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Custom Synthetic Genes Market Size (2021-2032)
- 10.2 South America Custom Synthetic Genes Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Custom Synthetic Genes Market Size by Country (2021-2026)
- 10.4 South America Custom Synthetic Genes Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Custom Synthetic Genes Market Size (2021-2032)
- 11.2 Middle East & Africa Custom Synthetic Genes Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Custom Synthetic Genes Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Custom Synthetic Genes Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Azenta Life Sciences
- 12.1.1 Azenta Life Sciences Company Information
- 12.1.2 Azenta Life Sciences Business Overview
- 12.1.3 Azenta Life Sciences Revenue in Custom Synthetic Genes Business (2021-2026)
- 12.1.4 Azenta Life Sciences Custom Synthetic Genes Product Portfolio
- 12.1.5 Azenta Life Sciences Recent Developments
- 12.2 BBI
- 12.2.1 BBI Company Information
- 12.2.2 BBI Business Overview
- 12.2.3 BBI Revenue in Custom Synthetic Genes Business (2021-2026)
- 12.2.4 BBI Custom Synthetic Genes Product Portfolio
- 12.2.5 BBI Recent Developments
- 12.3 Bio Basic
- 12.3.1 Bio Basic Company Information
- 12.3.2 Bio Basic Business Overview
- 12.3.3 Bio Basic Revenue in Custom Synthetic Genes Business (2021-2026)
- 12.3.4 Bio Basic Custom Synthetic Genes Product Portfolio
- 12.3.5 Bio Basic Recent Developments
- 12.4 DNA 2.0 (ATUM)
- 12.4.1 DNA 2.0 (ATUM) Company Information
- 12.4.2 DNA 2.0 (ATUM) Business Overview
- 12.4.3 DNA 2.0 (ATUM) Revenue in Custom Synthetic Genes Business (2021-2026)
- 12.4.4 DNA 2.0 (ATUM) Custom Synthetic Genes Product Portfolio
- 12.4.5 DNA 2.0 (ATUM) Recent Developments
- 12.5 Eurofins Genomics
- 12.5.1 Eurofins Genomics Company Information
- 12.5.2 Eurofins Genomics Business Overview
- 12.5.3 Eurofins Genomics Revenue in Custom Synthetic Genes Business (2021-2026)
- 12.5.4 Eurofins Genomics Custom Synthetic Genes Product Portfolio
- 12.5.5 Eurofins Genomics Recent Developments
- 12.6 Genescript
- 12.6.1 Genescript Company Information
- 12.6.2 Genescript Business Overview
- 12.6.3 Genescript Revenue in Custom Synthetic Genes Business (2021-2026)
- 12.6.4 Genescript Custom Synthetic Genes Product Portfolio
- 12.6.5 Genescript Recent Developments
- 12.7 IDT
- 12.7.1 IDT Company Information
- 12.7.2 IDT Business Overview
- 12.7.3 IDT Revenue in Custom Synthetic Genes Business (2021-2026)
- 12.7.4 IDT Custom Synthetic Genes Product Portfolio
- 12.7.5 IDT Recent Developments
- 12.8 OriGene
- 12.8.1 OriGene Company Information
- 12.8.2 OriGene Business Overview
- 12.8.3 OriGene Revenue in Custom Synthetic Genes Business (2021-2026)
- 12.8.4 OriGene Custom Synthetic Genes Product Portfolio
- 12.8.5 OriGene Recent Developments
- 12.9 SBS Genetech
- 12.9.1 SBS Genetech Company Information
- 12.9.2 SBS Genetech Business Overview
- 12.9.3 SBS Genetech Revenue in Custom Synthetic Genes Business (2021-2026)
- 12.9.4 SBS Genetech Custom Synthetic Genes Product Portfolio
- 12.9.5 SBS Genetech Recent Developments
- 12.10 Thermo Scientific
- 12.10.1 Thermo Scientific Company Information
- 12.10.2 Thermo Scientific Business Overview
- 12.10.3 Thermo Scientific Revenue in Custom Synthetic Genes Business (2021-2026)
- 12.10.4 Thermo Scientific Custom Synthetic Genes Product Portfolio
- 12.10.5 Thermo Scientific Recent Developments
- 12.11 Twist Bioscience
- 12.11.1 Twist Bioscience Company Information
- 12.11.2 Twist Bioscience Business Overview
- 12.11.3 Twist Bioscience Revenue in Custom Synthetic Genes Business (2021-2026)
- 12.11.4 Twist Bioscience Custom Synthetic Genes Product Portfolio
- 12.11.5 Twist Bioscience Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst